Grunnleggende statistikk
LEI | 529900OAC2X8QEPM8R89 |
CIK | 1084577 |
SEC Filings
SEC Filings (Chronological Order)
July 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-26495 CYREN LTD. (Exact name of registrant as specified in its charter) |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 S-8 POS 1 ea174401-s8poscyrenltd.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. 333-223050 Registration Statement No. 333-238269 Registration Statement No. 333-267452 Registration Statement No. 333-180453 Registration Statement No. 333-174748 Registration Statement No. 333-162104 Registration Statement No. 333-151929 |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 S-8 POS 1 ea174401-s8poscyrenltd.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. 333-223050 Registration Statement No. 333-238269 Registration Statement No. 333-267452 Registration Statement No. 333-180453 Registration Statement No. 333-174748 Registration Statement No. 333-162104 Registration Statement No. 333-151929 |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 26, 2023 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 28, 2023 |
As filed with the Securities and Exchange Commission on February 28, 2023 As filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No. |
|
February 22, 2023 |
Exhibit 99.1 Cyren Announces Liquidation MCLEAN, VA – February 22, 2023 / Cyren (NASDAQ:CYRN), a provider of email inbox security and threat detection solutions, today announced that, in response to its inability to secure additional sources of liquidity or consummate a going concern sale, as previously disclosed, the Board of Directors of the Company approved a plan to cease operations and commen |
|
February 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 22, 2023 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
February 22, 2023 |
Cyren Announces Nasdaq Delisting Determination Exhibit 99.1 Cyren Announces Nasdaq Delisting Determination MCLEAN, VA – February 22, 2023 / Cyren (NASDAQ:CYRN), a provider of email inbox security and threat detection solutions, today announced that, in response to its planned liquidation, the Company received written notice from Nasdaq, advising it that based upon Nasdaq’s review and pursuant to Listing Rule 5101, 5110(b) and IM-5101-1, Nasdaq |
|
February 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 20, 2023 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
February 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 1, 2023 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
February 6, 2023 |
Cyren Announces Global Reduction in Force; Liquidity Challenges Exhibit 99.1 Cyren Announces Global Reduction in Force; Liquidity Challenges MCLEAN, VA – February 1, 2023 / Cyren (NASDAQ:CYRN), a provider of inbox security and threat detection solutions, today announced that, in response to current market conditions and associated challenges with raising additional capital, the Company approved a plan to reduce its workforce by approximately 121 employees, rep |
|
January 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 12, 2023 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
December 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 29, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
November 14, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 14, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
November 14, 2022 |
Exhibit 99.1 PRESS RELEASE Cyren Announces Third Quarter 2022 Financial Results - - - Q3 Enterprise Anti-Phishing ARR Grows 74% Year-over-Year Driven by Increased Demand McLean, VA. ? November 14, 2022 ? Cyren (NASDAQ: CYRN) today announced its third quarter 2022 financial results for the period ending September 30, 2022. Cyren reported quarterly revenues of $5.8 million for the third quarter of 2 |
|
November 14, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-2649 |
|
September 16, 2022 |
Exhibit 107 FORM S-8 (Form Type) CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Table I: Newly Issued Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Share(3) Maximum Aggregate Offering Price(3) Fee Rate Amount of Registration Fee Equity Ordinary Shares Other 790,000 (2) $ 1.37 (3) $ 1,082,300 (3) $ 92.7 |
|
September 16, 2022 |
As filed with the Securities and Exchange Commission on September 16, 2022 As filed with the Securities and Exchange Commission on September 16, 2022 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CYREN LTD. (Exact name of registrant as specified in its charter) Israel Not applicable (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identificat |
|
September 6, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 31, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
August 24, 2022 |
CYREN LTD. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561 CORRESP 1 filename1.htm CYREN LTD. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561 011–972–9–863–6888 August 24, 2022 SUBMISSION VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attn: Charli Gibbs-Tabler Re: Cyren Ltd. Registration Statement on Form S-3 Filed: July 28, 2022 File No.: 333-266392 Ladies and Gentlemen: Purs |
|
August 22, 2022 |
August 22, 2022 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Officer of Technology 100 F Street, N. |
|
August 15, 2022 |
Exhibit 99.1 PRESS RELEASE Cyren Announces Second Quarter 2022 Financial Results - - - Enterprise Anti-Phishing ARR Grows 87% Year-over-Year and Core Threat Detection Business Exceeds Expectations McLean, VA. ? August 15, 2022 ? Cyren (NASDAQ: CYRN) today announced its second quarter 2022 financial results for the period ending June 30, 2022. Cyren reported quarterly revenues of $5.8 million for t |
|
August 15, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 15, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
August 15, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-26495 CYR |
|
August 5, 2022 |
Sale and Purchase Agreement between Cyren Ltd. and Content Services Group GmbH Exhibit 2.1 Executed Version Project Fortress SALE AND PURCHASE AGREEMENT between CYREN LTD. and Content Services Group GmbH Page 2 Sale and Purchase Agreement THIS AGREEMENT is made among the following parties: (1)CYREN LTD., a company organized and existing under the laws of the State of Israel with its registered office at 10 Ha-Menofim St., 5th Floor, Herzliya, Israel 4672561, and registered w |
|
August 5, 2022 |
CYREN LTD. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.1 CYREN LTD. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS On August 1, 2022, Cyren Ltd. (the ?Company? or ?Cyren?) completed the previously announced sale of all the equity interests in its legacy secure email gateway business and wholly owned subsidiary, Cyren GmbH (the ?Transaction?) for a total purchase price of EUR 10 million, subject to customary post-closing adj |
|
August 5, 2022 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 1, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
August 3, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 3, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
August 3, 2022 |
Cyren Successfully Completes Sale of its Legacy Secure Email Gateway Business Exhibit 99.1 PRESS RELEASE Cyren Successfully Completes Sale of its Legacy Secure Email Gateway Business McLean, VA ? August 3, 2022 / Cyren Ltd. (NASDAQ: CYRN), a provider of next-generation email protection and embedded threat detection solutions, today announced that it has completed the previously announced divestment of its legacy secure email gateway business to Content Services Group GmbH f |
|
August 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
July 28, 2022 |
Exhibit 107 Calculation of Filing Fee Table Form S-3 (Form Type) Cyren Ltd. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Numbe |
|
July 28, 2022 |
As filed with the Securities and Exchange Commission on July 28, 2022 As filed with the Securities and Exchange Commission on July 28, 2022 Registration Statement No. |
|
July 28, 2022 |
Exhibit 4.1 CYREN Ltd. and [?] Trustee INDENTURE Dated as of [?] SENIOR DEBT SECURITIES CROSS-REFERENCE TABLE(1) ACTIVE 65770231v2 Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4. |
|
July 28, 2022 |
Form of Subordinated Indenture Exhibit 4.2 CYREN Ltd. And Trustee INDENTURE Dated as of SUBORDINATED DEBT SECURITIES Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4.02 314(b) Inapplicable 314(c) 2.04 8.04 9.01( |
|
July 28, 2022 |
Exhibit 4.4 Form of Subordinated Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE |
|
July 28, 2022 |
Exhibit 4.3 Form of Senior Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE |
|
July 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 8, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
July 12, 2022 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
June 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 7, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
June 7, 2022 |
Cyren Announces Divestment to Enable Focus on Strategic Growth Opportunities Exhibit 99.1 PRESS RELEASE Cyren Announces Divestment to Enable Focus on Strategic Growth Opportunities MCLEAN, VA ? June 7, 2022 / Cyren (NASDAQ:CYRN), a provider of inbox security and threat intelligence solutions, today announced that it has entered into a definitive agreement to divest its legacy Secure Email Gateway business to Content Services Group GmbH for ?10,000,000 in cash. The purchase |
|
May 17, 2022 |
Exhibit 99.1 PRESS RELEASE Cyren Announces First Quarter 2022 Financial Results - - - Enterprise Anti-Phishing ARR Grows 111% Year-over-Year as Cyren Inbox Security Momentum Continues to Build McLean, VA. ? May 16, 2022 ? Cyren (NASDAQ: CYRN) today announced its first quarter 2022 financial results for the period ending March 31, 2022. During the first quarter of 2022, Cyren reported quarterly rev |
|
May 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 16, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000?26495 CYREN LTD. (Exact na |
|
March 30, 2022 |
Cyren Ltd. Up to 6,445,895 Ordinary Shares Filed Pursuant to Rule 424(b)(3) Registration No. 333-262926 PROSPECTUS Cyren Ltd. Up to 6,445,895 Ordinary Shares This prospectus relates to the proposed resale from time to time of up to 6,445,895 ordinary shares by the selling shareholders named in this prospectus. The shares to be sold under this prospectus consist of (i) 760,757 ordinary shares, (ii) 2,368,318 ordinary shares issuable upon th |
|
March 29, 2022 |
cyren Ltd. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561 CORRESP 1 filename1.htm cyren Ltd. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561 011–972–9–863–6888 March 29, 2022 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Jeff Kauten Josh Shainess Re: Cyren Ltd. Registration Statement on Form S-3, as amended (File No. 333-262926) Request for Acceleration of Effectiv |
|
March 24, 2022 |
Exhibit 4.1 DESCRIPTION OF SECURITIES As of March 1, 2022, the ordinary shares of Cyren Ltd. (?we,? ?us,? ?our? or the ?Company?) were the Company?s only class of securities registered under Section 12(b) of the Securities Exchange Act of 1934, as amended. The following description of our share capital is intended as a summary only and therefore is not a complete description of our share capital. |
|
March 24, 2022 |
2016 Non-Employee Director Equity Incentive Plan, as amended and restated.†* Exhibit 10.2 CYREN, LTD. 2016 NON-EMPLOYEE DIRECTOR EQUITY INCENTIVE PLAN Table of Contents Page 1. Establishment, Purpose and Term of Plan 1 1.1 Establishment 1 1.2 Purpose 1 1.3 Term of Plan 1 2. Definitions and Construction 1 2.1 Definitions 1 2.2 Construction 5 3. Administration 5 3.1 Administration by the Committee 5 3.2 Administration with Respect to Insiders 5 3.3 Powers of the Committee 5 |
|
March 24, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2022 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Emplo |
|
March 24, 2022 |
As filed with the Securities and Exchange Commission on March 24, 2022 As filed with the Securities and Exchange Commission on March 24, 2022 Registration No. |
|
March 24, 2022 |
2016 Equity Incentive Plan, as amended and restated.†* Exhibit 10.1 CYREN, LTD. 2016 EQUITY INCENTIVE PLAN Table of Contents Page 1. Establishment, Purpose and Term of Plan 1 1.1 Establishment 1 1.2 Purpose 1 1.3 Term of Plan 1 2. Definitions and Construction 1 2.1 Definitions 1 2.2 Construction 6 3. Administration 6 3.1 Administration by the Committee 6 3.2 Authority of Officers 6 3.3 Administration with Respect to Insiders 6 3.4 Powers of the Commit |
|
March 24, 2022 |
Exhibit 99.1 PRESS RELEASE Cyren Announces Fourth Quarter and Full Year 2021 Financial Results - - - Enterprise Anti-Phishing ARR Grows 87% Year-over-Year McLean, VA. ? March 24, 2022 ? Cyren (NASDAQ: CYRN) today announced its fourth quarter and full year 2021 financial results for the period ending December 31, 2021. During the fourth quarter of 2021, Cyren reported quarterly revenues of $7.4 mil |
|
March 24, 2022 |
Eric Blanchard +1 212 479 6565 [email protected] Via EDGAR March 24, 2022 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, N.E. Washington, D.C. 20549 Attention: Jeff Kauten Josh Shainess Re: Cyren Ltd. Registration Statement on Form S-3 Filed February 23, 2022 File No. 333-262926 Dear Mr. Kauten and Mr. Shainess: On behalf of Cyren Ltd |
|
March 24, 2022 |
List of Subsidiaries of the Company.* Exhibit 21 List of Subsidiaries of the Company Subsidiary Jurisdiction of Incorporation/Organization Ownership Cyren Inc. Delaware 100 % Cyren Iceland hf Iceland 100 % Cyren Gesellschaft mbH Germany 100 % Cyren UK Ltd. United Kingdom 100 % |
|
March 24, 2022 |
Executive Employment Agreement dated May 16, 2013, between Cyren Ltd. and Lior Kohavi. Exhibit 10.21 Translated from the Hebrew Lior Kohavi Employment Agreement Made and entered into in Herzliya on May 16, 2013 Between Commtouch Software Ltd. Address: 1 Sapir Street, Herzliya (hereinafter: the ?Company?) and Name: Lior Kohavi Identity No. 024966509 Address: 7 Ela Street, Ramat Hasharon (hereinafter: the ?Employee?) Whereas The Company wishes to employ the Employee in the position of |
|
March 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-26495 CYREN LTD. (Exact name of |
|
February 25, 2022 |
Cyren Regains Compliance with Nasdaq Listing Requirements Exhibit 99.1 PRESS RELEASE Cyren Regains Compliance with Nasdaq Listing Requirements McLean, Va. ? February 25, 2022 ? Cyren Ltd. (Nasdaq: CYRN) today announced it received formal notification from the Listing Qualifications Staff of the Nasdaq Stock Market Inc. (?Nasdaq?) that the Company has regained compliance with Listing Rule 5550(a)(2), which requires the Company to maintain a minimum closin |
|
February 25, 2022 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 25, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
February 23, 2022 |
Exhibit 107 Calculation of Filing Fee Table Form S-3 (Form Type) Cyren Ltd. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Numbe |
|
February 23, 2022 |
As filed with the Securities and Exchange Commission on February 23, 2022 As filed with the Securities and Exchange Commission on February 23, 2022 Registration No. |
|
February 14, 2022 |
Form of Placement Agent Warrant Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
February 14, 2022 |
Cyren Announces $12 Million Private Placement Priced At-the-Market Exhibit 99.1 PRESS RELEASE Cyren Announces $12 Million Private Placement Priced At-the-Market McLean, Va. ? February 10, 2022 ? Cyren (Nasdaq: CYRN), today announced that it has entered into a securities purchase agreement with certain institutional and other accredited investors to raise approximately $12 million through the issuance of 3,129,075 of its ordinary shares (or ordinary share equivale |
|
February 14, 2022 |
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 10, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
February 14, 2022 |
CYRN / Cyren Ltd / CVI Investments, Inc. - SC 13G/A Passive Investment CUSIP No: M26895108 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2. (Amendment No. 1)* Cyren Ltd. (Name of Issuer) Ordinary Shares, ILS 0.15 par value per share (Title of Class of Securities) M26895108 (CUSIP Number) Dece |
|
February 14, 2022 |
Cyren Announces Closing of $12 Million Private Placement Priced At-the-Market EX-99.2 8 ea155532ex99-2cyrenltd.htm PRESS RELEASE ISSUED BY CYREN LTD. ON FEBRUARY 14, 2022 Exhibit 99.2 PRESS RELEASE Cyren Announces Closing of $12 Million Private Placement Priced At-the-Market McLean, Va. – February 14, 2022 – Cyren Ltd. (Nasdaq: CYRN), today announced the closing of its previously announced private placement through asecurities purchase agreement with certain institutional a |
|
February 14, 2022 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of February 10, 2022, between Cyren Ltd., an Israeli corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively the ?Purchasers?). WHEREAS, subject to the terms and conditions set forth |
|
February 14, 2022 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this ?Agreement?) is made and entered into as of February 10, 2022, by and between Cyren Ltd., an Israeli corporation (the ?Company?), and each of the several purchasers signatory hereto (each such purchaser, a ?Purchaser? and, collectively, the ?Purchasers?). This Agreement is made pursuant to the Securities Purchase A |
|
February 14, 2022 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
February 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 10, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
February 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2022 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
February 9, 2022 |
Cyren Announces Reverse Share Split Exhibit 99.1 Press Release Cyren Announces Reverse Share Split McLean, VA ? February 8, 2022 ? Today, Cyren Ltd. (NASDAQ:CYRN), (the ?Company?) a provider of email security and threat intelligence solutions announced that it intends to effect a one-for-twenty reverse split of its ordinary shares (the "Reverse Share Split"). The Reverse Share Split will be effective as of 5:00 p.m. Eastern Time on |
|
February 9, 2022 |
Amended and Restated Articles of Association, as amended on February 8, 2022 Exhibit 3.2 THE COMPANIES LAW A COMPANY LIMITED BY SHARES AMENDED AND RESTATED ARTICLES OF ASSOCIATION of CYREN LTD. 1. Preliminary 1.1. Construction. In these Articles, each of the following terms shall have the respective meaning appearing next to it, if not inconsistent with the subject or context: 1.1.1. ?Articles? - These Articles of Association, as amended from time to time. 1.1.2. ?Board? - |
|
February 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 8)* Cyren Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.15 per share (Title of Class of Securities) M26895108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu |
|
January 5, 2022 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
December 15, 2021 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
December 9, 2021 |
Cyren Announces Repayment of Convertible Notes Debt Balance reduced by 52% Exhibit 99.1 Press Release Cyren Announces Repayment of Convertible Notes Debt Balance reduced by 52% McLean, VA ? December 9, 2021 ? Today, Cyren Ltd. (NASDAQ:CYRN), a provider of email security and threat intelligence solutions announced that it has paid in full the outstanding principal amount of $10M, along with accrued interest, on unsecured convertible notes issued in December 2018 with a ma |
|
December 9, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 2, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
November 16, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 15, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000–26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
November 16, 2021 |
Exhibit 99.1 PRESS RELEASE Cyren Announces Third Quarter 2021 Financial Results - - - Cyren Inbox Security Momentum Continues as Customer Transactions Increase 36% Quarter-over-Quarter McLean, Va. ? November 15, 2021 ? Cyren (NASDAQ: CYRN) today announced its third quarter 2021 financial results for the period ending September 30, 2021. During the third quarter, Cyren reported quarterly revenues o |
|
November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-26495 CYREN LTD. (Exac |
|
October 8, 2021 |
Cyren Ltd. 29,154,725 Ordinary Shares Pursuant to Rule 424(b)(3) Registration No.: 333-259959 PROSPECTUS Cyren Ltd. 29,154,725 Ordinary Shares This prospectus relates to the proposed resale from time to time of up to 29,154,725 ordinary shares by the selling shareholders named in this prospectus (together with any of such shareholders? pledgees, assignees, and successors-in-interest). The shares to be sold under this prospectus consis |
|
October 6, 2021 |
Nasdaq Grants Cyren 180-Day Extension to Meet Minimum Bid Price Requirement Exhibit 99.1 PRESS RELEASE Nasdaq Grants Cyren 180-Day Extension to Meet Minimum Bid Price Requirement McLean, VA ? October 6, 2021 ? Today, Cyren (NASDAQ:CYRN), a provider of email security and threat intelligence solutions, announced that the Company received written notification from the Listing Qualification Department of The NASDAQ Capital Market (?Nasdaq?) granting the Company?s request for |
|
October 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 6, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
October 5, 2021 |
CYREN LTD. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561 CYREN LTD. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561 011?972?9?863?6888 October 5, 2021 SUBMISSION VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attn: Jan Woo Re: Cyren Ltd. Registration Statement on Form S-3 Filed: October 1, 2021 File No.: 333-259959 Ladies and Gentlemen: Pursuant to Rule 461 under the Securit |
|
October 1, 2021 |
As filed with the Securities and Exchange Commission on October 1, 2021 As filed with the Securities and Exchange Commission on October 1, 2021 Registration No. |
|
October 1, 2021 |
Amended and Restated Articles of Association, as amended on September 9, 2021 Exhibit 4.2 THE COMPANIES LAW A COMPANY LIMITED BY SHARES AMENDED AND RESTATED ARTICLES OF ASSOCIATION of CYREN LTD. 1. Preliminary 1.1. Construction. In these Articles, each of the following terms shall have the respective meaning appearing next to it, if not inconsistent with the subject or context: 1.1.1. ?Articles? ? These Articles of Association, as amended from time to time. 1.1.2. ?Board? ? |
|
September 20, 2021 |
Cyren Announces $10.2 Million Private Placement Priced at a Premium to Market Exhibit 99.1 PRESS RELEASE Cyren Announces $10.2 Million Private Placement Priced at a Premium to Market McLean, Va. ? September 15, 2021 ? Cyren (Nasdaq: CYRN), today announced that it has entered into securities purchase agreements with certain institutional and other accredited investors to raise approximately $10.2 million through the issuance of 14,152,779 of its ordinary shares (or ordinary |
|
September 20, 2021 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of September 15, 2021, between Cyren Ltd., an Israeli corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively the ?Purchasers?). WHEREAS, subject to the terms and conditions set fort |
|
September 20, 2021 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
September 20, 2021 |
Form of Placement Agent Warrant Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
September 20, 2021 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this ?Agreement?) is made and entered into as of September 15, 2021, by and between Cyren Ltd., an Israeli corporation (the ?Company?), and each of the several purchasers signatory hereto (each such purchaser, a ?Purchaser? and, collectively, the ?Purchasers?). This Agreement is made pursuant to the Securities Purchase |
|
September 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 15, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
August 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Empl |
|
August 16, 2021 |
Exhibit 99.1 PRESS RELEASE Cyren Announces Second Quarter 2021 Financial Results - - - Cyren Inbox Security, Anti-Phishing for the Enterprise, Achieves Record ARR Growth McLean, Va. ? August 16, 2021 ? Cyren (NASDAQ: CYRN) today announced its second quarter 2021 financial results for the period ending June 30, 2021. During the second quarter, Cyren reported quarterly revenues of $7.6 million, comp |
|
August 16, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2021 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Empl |
|
August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-26495 CYREN LTD. (Exact nam |
|
July 13, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) July 8, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000-26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
June 3, 2021 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
May 18, 2021 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
May 17, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2021 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000?26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employe |
|
May 17, 2021 |
EXHIBIT 99.1 PRESS RELEASE Cyren Announces First Quarter 2021 Financial Results - - - Cyren Continues to Gain Traction in the Anti-Phishing Market with Cyren Inbox Security McLean, Va. ? May 17, 2021 ? Cyren (NASDAQ: CYRN) today announced its first quarter 2021 financial results for the period ending March 31, 2021. During the first quarter, Cyren reported quarterly revenues of $8.8 million, compa |
|
May 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000?26495 CYREN LTD. (Exact na |
|
April 13, 2021 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2021 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000?26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employ |
|
March 30, 2021 |
Exhibit 4.1 DESCRIPTION OF SECURITIES As of December 31, 2020, the ordinary shares of Cyren Ltd. (?we,? ?us,? ?our? or the ?Company?) were the Company?s only class of securities registered under Section 12(b) of the Securities Exchange Act of 1934, as amended. The following description of our share capital is intended as a summary only and therefore is not a complete description of our share capit |
|
March 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000?26495 CYREN LTD. (Exact name of |
|
March 30, 2021 |
List of Subsidiaries of the Company.* Exhibit 21 List of Subsidiaries of the Company Subsidiary Jurisdiction of Incorporation/Organization Ownership Cyren Inc. Delaware 100 % Cyren Iceland hf Iceland 100 % Cyren Gesellschaft mbH Germany 100 % Cyren UK Ltd. United Kingdom 100 % |
|
February 22, 2021 |
Cyren Announces Fourth Quarter and Full Year 2020 Financial Results - - - EX-99.1 2 ea136191ex99-1cyrenltd.htm PRESS RELEASE OF CYREN LTD. DATED FEBRUARY 22, 2021 Exhibit 99.1 PRESS RELEASE Cyren Announces Fourth Quarter and Full Year 2020 Financial Results - - - McLean, VA. – February 22, 2021 – Cyren (NASDAQ: CYRN) today announced its fourth quarter and full year 2020 financial results for the period ending December 31, 2020. During the fourth quarter, Cyren reported |
|
February 22, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2021 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000?26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Em |
|
February 19, 2021 |
CUSIP No: M26895108 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2. (Amendment No. )* Cyren Ltd. (Name of Issuer) Ordinary Shares, ILS 0.15 par value per share (Title of Class of Securities) M26895108 (CUSIP Number) Febru |
|
February 16, 2021 |
EX-10.2 5 ea135591ex10-2cyren.htm ENGAGEMENT AGREEMENT, DATED FEBRUARY 10, 2021, BY AND BETWEEN CYREN LTD. AND H.C. WAINWRIGHT & CO, LLC Exhibit 10.2 Execution Version February 10, 2021 STRICTLY CONFIDENTIAL Cyren Ltd. 10 Ha-Menofim St., 5th Floor Herzliya, Israel 4672561 Attn: Brett Jackson, Chief Executive Officer Dear Mr. Jackson: This letter agreement (this “Agreement”) constitutes the agreeme |
|
February 16, 2021 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of February 11, 2021, between Cyren Ltd., an Israeli corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively the ?Purchasers?). WHEREAS, subject to the terms and conditions set forth |
|
February 16, 2021 |
Cyren Announces $13.8 Million Registered Direct Offering of Ordinary Shares Exhibit 99.1 Cyren Announces $13.8 Million Registered Direct Offering of Ordinary Shares McLean, VA, Feb. 11, 2021 – Cyren, Ltd. (NASDAQ: CYRN), a provider of email security and threat intelligence solutions, today announced that it has entered into securities purchase agreements with several institutional investors for the purchase and sale, in a registered direct offering, of 12,000,000 of its o |
|
February 16, 2021 |
Form of Placement Agent Warrant Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
February 16, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 10, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000?26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
February 16, 2021 |
CYREN LTD. 12,000,000 Ordinary Shares Filed Pursuant to Rule 424(b)(5) Registration No. 333-233316 Prospectus Supplement to Prospectus dated August 16, 2019 CYREN LTD. 12,000,000 Ordinary Shares We are offering 12,000,000 of our ordinary shares, par value ILS 0.15 per share (the “ordinary shares”), at an offering price of $1.15 per share, directly to certain investors, referred to as “the investors.” Our ordinary shares are listed on |
|
February 11, 2021 |
Results of Operations and Financial Condition - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 11, 2021 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000–26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
February 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 7)* Cyren Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.15 per share (Title of Class of Securities) M26895108 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu |
|
January 27, 2021 |
Supplemental Letter Agreement dated January 26, 2021 Exhibit 10.2 January 26, 2021 Re: Supplemental Employment Terms Mr. Kenneth Tarpey 10590 Mountain Shadow Lane Marshall, VA 20115 Dear Ken: The purpose of this letter agreement (the “Letter Agreement”) is to confirm our agreement that in the event that (i) your employment is Involuntarily Terminated by Cyren Ltd. or its successor (as applicable, the “Company”), and (ii) such termination occurs with |
|
January 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2021 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File |
|
January 27, 2021 |
Offer Letter dated January 26, 2021 Exhibit 10.1 January 26, 2021 Mr. Kenneth Tarpey 10590 Mountain Shadow Lane Marshall, VA 20115 VIA ELECTRONIC MAIL Dear Ken, On behalf of Cyren Inc. (the “Company”), I am pleased to offer you the position of Chief Financial Officer reporting to Brett Jackson, Chief Executive Officer. Commencement Date: Provided you accept the offer contained herein by January 27, 2021 and provided the undersigned |
|
January 27, 2021 |
Cyren Announces Appointment of Kenneth Tarpey as Chief Financial Officer Exhibit 99.1 PRESS RELEASE Cyren Announces Appointment of Kenneth Tarpey as Chief Financial Officer McLean, Va. – January 27, 2021 – Cyren (NASDAQ: CYRN), a provider of email security and threat intelligence solutions, today announced that Kenneth Tarpey will join the Company as Chief Financial Officer, replacing Michael Myshrall, who, after ten years with the company, is moving on to pursue other |
|
January 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2021 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. |
|
November 16, 2020 |
Exhibit 99.1 PRESS RELEASE Cyren Reports Third Quarter 2020 Financial Results - - - Cyren Inbox Security continues to gain momentum supporting company’s growth strategy McLean, Va. – November 16, 2020 – Cyren (NASDAQ: CYRN), a provider of email security and threat intelligence solutions, today announced its third quarter 2020 financial results for the period ending September 30, 2020. “The third q |
|
November 16, 2020 |
Results of Operations and Financial Condition, Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Em |
|
November 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exac |
|
August 12, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact nam |
|
August 12, 2020 |
Exhibit 99.1 PRESS RELEASE Cyren Reports Second Quarter 2020 Financial Results - - - Positive initial market traction with new strategy and enterprise offerings McLean, Va. – August 12, 2020 – Cyren (NASDAQ: CYRN), a provider of email security and threat intelligence solutions, today announced its second quarter 2020 financial results for the period ending June 30, 2020. “During the second quarter |
|
August 12, 2020 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Empl |
|
August 3, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employ |
|
June 25, 2020 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
June 12, 2020 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
June 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employe |
|
May 26, 2020 |
Cyren Ltd. 16,586,396 Ordinary Shares Pursuant to Rule 424(b)(3) Registration No. 333-238266 PROSPECTUS Cyren Ltd. 16,586,396 Ordinary Shares This prospectus relates to the proposed resale from time to time of up to 16,586,396 ordinary shares, par value ILS 0.15 per share, by the selling shareholders named herein, together with any additional selling shareholders listed in a prospectus supplement (together with any of such shareholder |
|
May 21, 2020 |
CYREN LTD. 10 Ha-Menofim St., 5th Floor Herzliya, Israel, 4672561 011–972–9–863–6888 May 21, 2020 SUBMISSION VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attn: Mr. Larry Spirgel Re: Cyren Ltd. Registration Statement on Form S-3 Filed May 14, 2020 File No. 333-238266 Ladies and Gentlemen: Pursuant to Rule 461 under the Secur |
|
May 14, 2020 |
As filed with the Securities and Exchange Commission on May 14, 2020 Registration No. |
|
May 14, 2020 |
As filed with the Securities and Exchange Commission on May 14, 2020 Registration No. |
|
May 13, 2020 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employe |
|
May 13, 2020 |
Exhibit 99.1 PRESS RELEASE Cyren Announces First Quarter 2020 Financial Results - - - Net Loss Decreases And Company Launches New Cloud-based Anti-Phishing Product for Enterprises McLean, Va. – May 13, 2020 – Cyren (NASDAQ: CYRN) today announced its first quarter 2020 financial results for the period ending March 31, 2020. During the first quarter, Cyren reported quarterly revenues of $9.6 million |
|
May 13, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact na |
|
April 30, 2020 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Emplo |
|
March 30, 2020 |
Exhibit 4.1 DESCRIPTION OF SECURITIES As of December 31, 2019, the ordinary shares of Cyren Ltd. (“we,” “us,” “our” or the “Company”) were the Company’s only class of securities registered under Section 12(b) of the Securities Exchange Act of 1934, as amended. The following description of our share capital is intended as a summary only and therefore is not a complete description of our share capit |
|
March 30, 2020 |
Exhibit 10.12 January 9, 2011 J. Michael Myshrall [redacted] Dear Michael, On behalf of Commtouch Inc. (“Company”), I am pleased to offer you the position of Vice President, Corporate Business Development, reporting to the CEO. Base Salary Your base salary is $16,666.66 per month, or approximately $200,000 on a yearly basis. Salary will be paid on a semi-monthly basis. Your employment shall remain |
|
March 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact name of |
|
March 30, 2020 |
List of Subsidiaries of the Company.* Exhibit 21 List of Subsidiaries of the Company Subsidiary Jurisdiction of Incorporation/Organization Ownership Cyren Inc. Delaware 100 % Cyren Iceland hf Iceland 100 % Cyren Gesellschaft mbH Germany 100 % Cyren UK Ltd. United Kingdom 100 % |
|
March 30, 2020 |
Summary of Director Compensation. Exhibit 10.5 SUMMARY OF DIRECTOR COMPENSATION The following is a summary of the compensation terms of the non-executive directors of Cyren Ltd. (the “Company”). At the Company’s 2019 Annual Meeting of Shareholders, the Company’s shareholders approved the following compensation for its non-executive directors, to remain in effect from the shareholder approval date of July 30, 2019: 1) Annual Cash C |
|
March 25, 2020 |
Exhibit 99.1 PRESS RELEASE Cyren Announces Fourth Quarter and Full Year 2019 Financial Results - - - Annual revenue increased 7% over prior year McLean, Va. – March 25, 2020 – Cyren (NASDAQ: CYRN) today announced its fourth quarter and full year 2019 financial results for the period ending December 31, 2019. During the fourth quarter, Cyren reported quarterly revenues of $9.5 million, compared to |
|
March 25, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2020 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Emplo |
|
March 19, 2020 |
EX-10.1 3 ea119750ex10-1cyren.htm FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF MARCH 16, 2020, BY AND AMONG CYREN LTD. AND THE PURCHASERS NAMED THEREIN Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of March 16, 2020, between Cyren Ltd., an Israeli corporation (the “Company”), and each purchaser identified on the signature pages h |
|
March 19, 2020 |
Form of Subsidiary Guarantee, dated as of March 19, 2020 EX-10.3 5 ea119750ex10-3cyren.htm FORM OF SUBSIDIARY GUARANTEE, DATED AS OF MARCH 16, 2020 Exhibit 10.3 SUBSIDIARY GUARANTEE SUBSIDIARY GUARANTEE, dated as of March 19, 2020 (this “Guarantee”), made by each of the signatories hereto (together with any other entity that may become a party hereto as provided herein, the “Guarantors”), in favor of the purchasers signatory (together with their permitt |
|
March 19, 2020 |
EX-10.2 4 ea119750ex10-2cyren.htm FORM OF REGISTRATION RIGHTS AGREEMENT, DATED AS OF MARCH 16, 2020, BY AND AMONG CYREN LTD. AND THE PURCHASERS NAMED THEREIN Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 16, 2020, between Cyren Ltd., an Israeli corporation (the “Company”), and each of the several purchasers sig |
|
March 19, 2020 |
Form of 5.75% Convertible Debenture Due 2024 Exhibit 4.1 EXHIBIT A NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECT |
|
March 19, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 19, 2020 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000–26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
March 17, 2020 |
Cyren Announces Private Placement of Convertible Debentures Exhibit 99.1 PRESS RELEASE Cyren Announces Private Placement of Convertible Debentures McLean, VA – March 17, 2020 – Cyren (NASDAQ: CYRN) announced today that it has entered into purchase agreements with a select group of accredited and institutional investors for the purchase of $10.25 million aggregate principal amount of convertible debentures in a private placement. The debentures will be unse |
|
March 17, 2020 |
Exhibit 99.2 |
|
March 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 16, 2020 CYREN LTD. (Exact Name of Registrant as Specified in its Charter) Israel 000–26495 Not applicable (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
February 10, 2020 |
CYRN / CYREN Ltd. / Wp Xii Investments B.v. - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5) Cyren Ltd. (Name of Issuer) Ordinary Shares, nominal value NIS 0.15 per share (Title of Class of Securities) M25596202 (CUSIP Number) Robert B. Knauss General Counsel and Managing Director Warburg Pincus LLC 450 Lexington Avenue New York, New York 10017 (212 |
|
February 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 6)* Cyren Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.15 per share (Title of Class of Securities) M26895108 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu |
|
November 13, 2019 |
CYRN / CYREN Ltd. 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exac |
|
November 13, 2019 |
Exhibit 99.1 PRESS RELEASE Cyren Announces Third Quarter 2019 Financial Results - - - Year-to-date revenue up 9% despite slight revenue decline during quarter McLean, Va. – November 13, 2019 – Cyren (NASDAQ: CYRN) today announced its third quarter 2019 financial results for the period ending September 30, 2019. During the third quarter, Cyren reported quarterly revenues of $9.5 million, compared t |
|
November 13, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Em |
|
November 12, 2019 |
CYRN / CYREN Ltd. / Wp Xii Investments B.v. - SCHEDULE 13D/A NO.4 Activist Investment Schedule 13D/A No.4 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4) Cyren Ltd. (Name of Issuer) Ordinary Shares, nominal value NIS 0.15 per share (Title of Class of Securities) M25596202 (CUSIP Number) Robert B. Knauss General Counsel and Managing Director Warburg Pincus LLC 450 Lexington Avenue New York, New York |
|
November 7, 2019 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Emp |
|
November 7, 2019 |
Cyren Announces Closing of Rights Offering Exhibit 99.1 PRESS RELEASE Cyren Announces Closing of Rights Offering McLean, Va. – November 7, 2019 – Cyren (NASDAQ: CYRN) announced today that its previously announced rights offering (the “Rights Offering”) closed on November 6, 2019 and generated approximately $8 million of gross proceeds. Cyren issued a total of 4,635,584 ordinary shares at $1.73 per share. This includes 4,624,277 shares issu |
|
October 4, 2019 |
Exhibit 99.3 FORM OF LETTER TO NOMINEE HOLDERS CYREN LTD. Subscription Rights to Purchase up to 7,240,808 Ordinary Shares October 4, 2019 To Securities Dealers, Commercial Banks, Trust Companies and Other Nominees: This letter is being distributed by Cyren Ltd. (the “Company”) to securities dealers, commercial banks, trust companies and other nominees in connection with a distribution in a rights |
|
October 4, 2019 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Empl |
|
October 4, 2019 |
Exhibit 99.1 FORM OF INSTRUCTIONS AS TO USE OF CYREN LTD. SUBSCRIPTION RIGHTS CERTIFICATES CONSULT THE INFORMATION AGENT, YOUR BANK OR YOUR BROKER AS TO ANY QUESTIONS The following instructions relate to a rights offering by Cyren Ltd., an Israeli company (“Company”), to the holders of record of its ordinary shares, as described in the Company’s prospectus supplement dated October 4, 2019 (the “Pr |
|
October 4, 2019 |
BENEFICIAL OWNER ELECTION FORM Exhibit 99.5 BENEFICIAL OWNER ELECTION FORM The undersigned acknowledge(s) receipt of your letter and the enclosed materials relating to the grant of non-transferable rights (the “Rights”) to subscribe for and purchase up to 7,240,808 ordinary shares (“Shares”) of Cyren Ltd. (the “Company”). With respect to any instructions to exercise (or not to exercise) Rights, the undersigned acknowledges that |
|
October 4, 2019 |
Exhibit 99.2 FORM OF LETTER TO RECORD HOLDERS CYREN LTD. Subscription Rights to Purchase up to 7,240,808 Ordinary Shares October 4, 2019 Dear Shareholder: This letter is being distributed by Cyren Ltd. (the “Company”) to all holders of record of its ordinary shares at 5:00 p.m., New York City time, on September 25, 2019 (the “Record Date”), in connection with a distribution in a rights offering (t |
|
October 4, 2019 |
EX-99.7 9 f8k100419ex99-7cyrenltd.htm FORM OF SUBSCRIPTION RIGHTS CERTIFICATE Exhibit 99.7 RIGHTS CERTIFICATE #: NUMBER OF RIGHTS THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANY’S PROSPECTUS SUPPLEMENT DATED OCTOBER 4, 2019 (THE “PROSPECTUS”) AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF THE PROSPECTUS ARE AVAILABLE UPON REQUEST FROM D.F. KING & CO., INC., THE IN |
|
October 4, 2019 |
Cyren Announces Commencement of Rights Offering Exhibit 99.8 PRESS RELEASE Cyren Announces Commencement of Rights Offering McLean, Va. – October 4, 2019 – Cyren (NASDAQ: CYRN) (the “Company”) announced today that it has commenced the previously announced rights offering to raise gross proceeds of approximately $12.5 million (the “Rights Offering”). Under the terms of the Rights Offering, the holders of the Company’s ordinary shares as of 5:00 p |
|
October 4, 2019 |
Exhibit 99.4 FORM OF LETTER TO CLIENTS OF NOMINEE HOLDERS CYREN LTD. Subscription Rights to Purchase up to 7,240,808 Ordinary Shares October 4, 2019 To Our Clients: Enclosed for your consideration is a prospectus supplement, dated October 4, 2019 to a prospectus dated August 16, 2019 (collectively, the “Prospectus”), which relates to the offering (the “Rights Offering”) of Cyren Ltd. (the “Company |
|
October 4, 2019 |
NOMINEE HOLDER CERTIFICATION CYREN LTD. Exhibit 99.6 NOMINEE HOLDER CERTIFICATION CYREN LTD. The undersigned, a broker, custodian bank, trustee, depositary or other nominee holder of non-transferable rights (the “Rights”) to subscribe for and purchase up to 7,240,808 ordinary shares (“Shares”) of Cyren Ltd. (the “Company”) pursuant to the rights offering described and provided for in the Company’s prospectus supplement, dated October 4, |
|
October 4, 2019 |
CYREN LTD. SUBSCRIPTION RIGHTS TO PURCHASE UP TO 7,240,808 ORDINARY SHARES Filed Pursuant to Rule 424(b)(5) Registration No. 333- 233316 PROSPECTUS SUPPLEMENT (to Prospectus dated August 16, 2019) CYREN LTD. SUBSCRIPTION RIGHTS TO PURCHASE UP TO 7,240,808 ORDINARY SHARES We are distributing at no charge to the holders of our ordinary shares as of the close of business on September 25, 2019, which we refer to as the record date, subscription rights to purchase up to an ag |
|
September 12, 2019 |
CYRN / CYREN Ltd. / Wp Xii Investments B.v. - SCHEDULE 13D/A NO.3 Activist Investment Schedule 13D/A No.3 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3) Cyren Ltd. (Name of Issuer) Ordinary Shares, nominal value NIS 0.15 per share (Title of Class of Securities) M25596202 (CUSIP Number) Robert B. Knauss General Counsel and Managing Director Warburg Pincus LLC 450 Lexington Avenue New York, New York |
|
September 12, 2019 |
WP XII Investments B.V. Atrium Strawinskylaan 3051 1077 ZX Amsterdam The Netherlands Exhibit E Exhibit E WP XII Investments B.V. Atrium Strawinskylaan 3051 1077 ZX Amsterdam The Netherlands September 11, 2019 Cyren Ltd. 10 Ha-Menofim St 5th Floor Herzliya 4672561, Israel Re: Rights Offering Commitment In connection with a contemplated Rights Offering of Cyren Ltd. (the “Company”) of up to $12.5 million to its shareholders as of the applicable record date, WP XII Investments BV (th |
|
September 11, 2019 |
Cyren Announces Rights Offering Exhibit 99.1 PRESS RELEASE Cyren Announces Rights Offering McLean, Va. – September 11, 2019 – Cyren (NASDAQ: CYRN) (the “Company”) announced today that its board of directors has approved a rights offering (the “Rights Offering”) to raise proceeds of up to $12,500,000. Pursuant to the Rights Offering, each holder of ordinary shares at the close of business on September 25, 2019 (the "Record Date") |
|
September 11, 2019 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. E |
|
August 26, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file nu |
|
August 19, 2019 |
Cyren Ltd. 10 Ha-Menofim St 5th Floor Herzliya 4672561, Israel August 19, 2019 Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Barbara C. Jacobs, Assistant Director Re: Cyren Ltd. Registration Statement on Form S-3 File No. 333-233316 Dear Ms. Jacobs: Cyren Ltd. (the “Company”) hereby requests acceleration of the effective date of |
|
August 16, 2019 |
Exhibit 4.3 Form of Senior Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE |
|
August 16, 2019 |
CYRN / CYREN Ltd. S-3 - - REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on August 16, 2019 Registration No. |
|
August 16, 2019 |
Form of Subordinated Indenture EX-4.2 3 fs32019ex4-2cyrenltd.htm FORM OF SUBORDINATED INDENTURE Exhibit 4.2 CYREN Ltd. and Trustee INDENTURE Dated as of SUBORDINATED DEBT SECURITIES Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 3 |
|
August 16, 2019 |
Exhibit 4.1 CYREN Ltd. and Trustee INDENTURE Dated as of SENIOR DEBT SECURITIES CROSS-REFERENCE TABLE(1) Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4.02 314(b) Inapplicable 314 |
|
August 16, 2019 |
EX-4.4 5 fs32019ex4-4cyrenltd.htm FORM OF SUBORDINATED NOTE Exhibit 4.4 Form of Subordinated Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOM |
|
August 14, 2019 |
Exhibit 99.1 PRESS RELEASE Cyren Announces Second Quarter 2019 Financial Results - - - First half revenue up 15% as quarterly revenue increases 6% year-over-year McLean, Va. – August 14, 2019 – Cyren (NASDAQ: CYRN) today announced its second quarter 2019 financial results for the period ending June 30, 2019. During the second quarter, Cyren reported quarterly revenues of $9.7 million – an increase |
|
August 14, 2019 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File N |
|
August 14, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact nam |
|
August 2, 2019 |
2016 Equity Incentive Plan, as amended and restated.† Exhibit 10.1 CYREN, LTD. 2016 EQUITY INCENTIVE PLAN 1 Table of Contents Page 1. Establishment, Purpose and Term of Plan 5 1.1 Establishment 5 1.2 Purpose 5 1.3 Term of Plan 5 2. Definitions and Construction 5 2.1 Definitions 5 2.2 Construction 10 3. Administration 10 3.1 Administration by the Committee 10 3.2 Authority of Officers 10 3.3 Administration with Respect to Insiders 10 3.4 Powers of the |
|
August 2, 2019 |
2016 Non-Employee Director Equity Incentive Plan, as amended and restated.† Exhibit 10.2 CYREN, LTD. 2016 NON-EMPLOYEE DIRECTOR EQUITY INCENTIVE PLAN 1 Table of Contents Page 1. Establishment, Purpose and Term of Plan 5 1.1 Establishment 5 1.2 Purpose 5 1.3 Term of Plan 5 2. Definitions and Construction 5 2.1 Definitions 5 2.2 Construction 9 3. Administration 9 3.1 Administration by the Committee 9 3.2 Administration with Respect to Insiders 9 3.3 Powers of the Committee |
|
August 2, 2019 |
Amended and Restated Articles of Association of the Company, as amended on July 30, 2019. Exhibit 3.1 THE COMPANIES LAW A COMPANY LIMITED BY SHARES AMENDED AND RESTATED ARTICLES OF ASSOCIATION of cyren LTD. 1. Preliminary 1.1. Construction. In these Articles, each of the following terms shall have the respective meaning appearing next to it, if not inconsistent with the subject or context: 1.1.1. “Articles” - These Articles of Association, as amended from time to time. 1.1.2. “Board” - |
|
August 2, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employ |
|
June 25, 2019 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
June 13, 2019 |
CYRN / CYREN Ltd. PRE 14A - - PRELIMINARY PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
May 23, 2019 |
Exhibit 99.1 PRESS RELEASE Cyren Expands Executive Team Announces Chief Strategy Officer and Appoints New Chief Technology Officer McLean, VA – May 23, 2019 – Cyren (NASDAQ: CYRN), a leader in cloud security, announced today that Lior Kohavi, who has served as Cyren’s Chief Technical Officer since joining the company in 2013, has been promoted to the newly created position of Chief Strategy Office |
|
May 23, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2019 CYREN LTD. (Exact name of Registrant as specified in its charter) Israel 000–26495 Not applicable (State or other jurisdiction of (Commission file number) (I.R.S. Employe |
|
May 15, 2019 |
Exhibit 99.1 PRESS RELEASE Cyren Announces First Quarter 2019 Financial Results - - - First quarter revenue increases 26% year-over-year McLean, Va. – May 15, 2019 – Cyren (NASDAQ: CYRN) today announced its first quarter 2019 financial results for the period ending March 31, 2019. During the first quarter, Cyren reported quarterly revenues of $9.7 million – an increase of 26% over the first quarte |
|
May 15, 2019 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File Numb |
|
May 15, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact na |
|
April 26, 2019 |
Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of the 23rd day of April, 2019 (the “Effective Date”) by and between Cyren Ltd. and Cyren Ltd.’s wholly owned U.S. subsidiary, Cyren Inc. (together, “Cyren” or “Company”) and Brett Michael Jackson, a Virginia resident (“Executive”). PRELIMINARY STATEMENTS A. The Company de |
|
April 26, 2019 |
Cyren Appoints Brett Jackson as New CEO Security veteran tapped to lead Cyren’s next phase of growth Exhibit 99.1 PRESS RELEASE Cyren Appoints Brett Jackson as New CEO Security veteran tapped to lead Cyren’s next phase of growth McLean, VA – April 24, 2019 – Cyren (NASDAQ: CYRN), a leader in cloud security, announced today that Brett Jackson has been appointed by Cyren’s Board of Directors to serve as the company’s next Chief Executive Officer commencing in May. Mr. Jackson will succeed Lior Samu |
|
April 26, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File Nu |
|
April 18, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* Cyren Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.15 per share (Title of Class of Securities) M26895108 (CUSIP Number) April 5, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua |
|
March 28, 2019 |
Form of Notice of Grant under the Non-Employee Director 2016 Equity Incentive Plan.† Exhibit 10.4 CYREN LTD. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (For Non-Employee Directors) Cyren Ltd. (the “Company”) has granted to the Participant an award (the “Award”) of certain units pursuant to the Cyren Ltd. 2016 Non-Employee Director Equity Incentive Plan (the “Plan”), each of which represents the right to receive on the applicable Settlement Date one (1) share of Stock, as follows: P |
|
March 28, 2019 |
Form of Notice of Grant under the 2016 Equity Incentive Plan.† Exhibit 10.3 CYREN LTD. NOTICE OF GRANT Cyren Ltd. (the “Company”) has granted to the Participant an award (the “Award”) of certain units pursuant to the Cyren Ltd. 2016 Equity Incentive Plan (the “Plan”), each of which represents the right to receive on the applicable Settlement Date one (1) share of Stock, as follows: Participant: Employee ID: Date of Grant: Total Number of Units: , subject to a |
|
March 28, 2019 |
Exhibit 10.7 THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE A |
|
March 28, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000–26495 CYREN LTD. (Exact name of |
|
March 28, 2019 |
List of Subsidiaries of the Company.* Exhibit 21 List of Subsidiaries of the Company Subsidiary Jurisdiction of Incorporation/Organization Ownership Cyren Inc. Delaware 100 % Cyren Iceland hf Iceland 100 % Cyren Gesellschaft mbH Germany 100 % Cyren UK Ltd. United Kingdom 100 % |
|
March 28, 2019 |
Employment Contract dated June 29, 2016 between Cyren GmbH and Atif Ahmed† Exhibit 10.13 EMPLOYMENT CONTRACT 1. CYREN GmbH and 2. Atif Ahmed 1 Term of Appointment 1 2 Employee warranties 1 3 Duties 1 4 Place of Work 2 5 Hours of Work 2 6 Salary 2 7 Expenses 2 8 Commission Payments 3 9 Private Insurance Contributions 3 10 Car Allowance 3 11 Holidays 3 12 Incapacity 4 13 Confidential Information 4 14 Intellectual Property 5 15 Payment in Lieu of Notice 5 16 Termination wit |
|
March 28, 2019 |
Translation of Employment Contract dated May 16, 2013 between Commtouch Ltd. and Lior Kohavi. †* Exhibit 10.12 Employment Agreement Made and entered into in Herzliya on May 16, 2013 Between Commtouch Software Ltd. 1 Sapir St., Herzliya (Hereinafter: the “Company”) And Name: Lior Kohavi 7 Ella St., Ramat HaSharon (Hereinafter: the “Employee”) Whereas the Company wishes to hire the Employee as CTO, all subject to and in accordance with the provisions of this agreement; The parties have therefor |
|
March 28, 2019 |
Offer Letter dated November 19, 2013 between Commtouch Inc. and Lior Samuelson. Exhibit 10.11 Lior Samuelson November 19, 2013 1304 Stamford Way Reston, VA 20194 Dear Lior, On behalf of Commtouch Inc. (the “Company”) and Commtouch Software Ltd, the Israeli based parent to the Company (“CTLTD”, together with the Company, “Commtouch”), I am pleased to offer you the position of Chief Executive Officer. While your base of operations shall be in the United States and your formal e |
|
February 20, 2019 |
Exhibit 99.1 PRESS RELEASE Cyren Announces CEO Transition Plan - - - Lior Samuelson will assist in CEO transition and continue as Chairman of the Board McLean, Va. – February 20, 2019 – Cyren (NASDAQ: CYRN) announced today that Lior Samuelson, Chairman and Chief Executive Officer, intends to step down as CEO after transitioning his responsibilities to a successor to be identified in the future by |
|
February 20, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File |
|
February 13, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File |
|
February 13, 2019 |
Exhibit 99.1 PRESS RELEASE Cyren Reports Fourth Quarter and Full Year 2018 Financial Results - - - Full year 2018 revenue grew 17% while fourth quarter revenue was up 26% year-over-year McLean, Va. – February 13, 2019 – Cyren (NASDAQ: CYRN) today announced its fourth quarter and full year 2018 financial results for the period ending December 31, 2018. During the fourth quarter, Cyren reported quar |
|
January 14, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4)* Cyren Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.15 per share (Title of Class of Securities) M26895108 (CUSIP Number) January 10, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
January 10, 2019 |
Cyren Announces Voluntary Delisting from the Tel Aviv Stock Exchange Exhibit 99.1 PRESS RELEASE Cyren Announces Voluntary Delisting from the Tel Aviv Stock Exchange McLean, VA – January 10, 2019 – Cyren (NASDAQ: CYRN), a leader in cloud security, today announced that it is voluntarily delisting the company’s ordinary shares from trading on the Tel Aviv Stock Exchange (TASE). Consequently, Cyren intends to apply to the TASE and request that TASE initiate the delisti |
|
January 10, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2019 Cyren Ltd. (Exact name of registrant as specified in its charter) Israel 000-26495 Not applicable (State or other jurisdiction of incorporation) (Commission File |
|
November 15, 2018 |
Cyren Announces $10 Million Note Offering - - - Exhibit 1 PRESS RELEASE Cyren Announces $10 Million Note Offering - - - McLean, Va. |
|
November 15, 2018 |
CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Off |
|
November 14, 2018 |
CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Off |
|
November 14, 2018 |
Cyren Announces Third Quarter 2018 Financial Results - - - Quarterly revenue up 26% year-over-year Exhibit 1 PRESS RELEASE Cyren Announces Third Quarter 2018 Financial Results - - - Quarterly revenue up 26% year-over-year McLean, Va. |
|
October 29, 2018 |
Exhibit 1 PRESS RELEASE Cyren Schedules Third Quarter 2018 Earnings Release for Wednesday, November 14, 2018 McLean, VA – October 29, 2018 – Cyren (NASDAQ: CYRN) today announced it will release its third quarter 2018 results on Wednesday, November 14, 2018 before U. |
|
October 29, 2018 |
CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Offi |
|
October 1, 2018 |
Cyren Ltd. 10 Ha-Menofim St 5th Floor Herzliya 4672561, Israel October 1, 2018 Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Matt Crispino, Staff Attorney Re: Cyren Ltd. Registration Statement on Form F-3 File No. 333-227493 Dear Mr. Crispino: Cyren Ltd. (the “Company”) hereby requests acceleration of the effective date of the a |
|
September 26, 2018 |
Exhibit 1 PRESS RELEASE Cyren Web Security Wins Second Consecutive CyberSecurity Breakthrough Award Cyren Web Security Solution Wins “Overall Secure Web Gateway Solution of the Year” Award McLean, VA – September 26, 2018 – Cyren (NASDAQ: CYRN), a leader in cloud security, today announced that its Cyren Web Security platform was named the winner of the “Overall Secure Web Gateway Solution of the Year” award for the second consecutive year from CyberSecurity Breakthrough, an independent organization that recognizes the top companies, technologies and products in the global information security market. |
|
September 26, 2018 |
CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Of |
|
September 24, 2018 |
Form of Subordinated Indenture Exhibit 4.4 CYREN Ltd. and Trustee INDENTURE Dated as of SUBORDINATED DEBT SECURITIES Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4.02 314(b) Inapplicable 314(c) 2.04 8.04 9.01( |
|
September 24, 2018 |
Exhibit 4.3 CYREN Ltd. and Trustee INDENTURE Dated as of SENIOR DEBT SECURITIES CROSS-REFERENCE TABLE(1) Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.03 314(a) 4.02 314(b) Inapplicable 314 |
|
September 24, 2018 |
CYRN / CYREN Ltd. REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on September 21, 2018 Registration No. |
|
September 24, 2018 |
Computation of Ratio of Earnings to Fixed Charges Exhibit 12 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES The following table contains our consolidated ratio of earnings (deficiency) to fixed charges for the periods indicated. |
|
September 24, 2018 |
Exhibit 4.6 Form of Subordinated Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE |
|
September 24, 2018 |
Amended and Restated Articles of Association of the Company, as amended on August 28, 2018. Exhibit 4.2 THE COMPANIES LAW A COMPANY LIMITED BY SHARES AMENDED AND RESTATED ARTICLES OF ASSOCIATION of cyren LTD. 1. Preliminary 1.1. Construction. In these Articles, each of the following terms shall have the respective meaning appearing next to it, if not inconsistent with the subject or context: 1.1.1. “Articles” - These Articles of Association, as amended from time to time. 1.1.2. “Board” - |
|
September 24, 2018 |
Exhibit 4.5 Form of Senior Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE |
|
September 21, 2018 |
EX-99.1 2 f6k092118ex99-1cyren.htm UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2018 Exhibit 99.1 CYREN LTD. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2018 U.S. DOLLARS IN THOUSANDS UNAUDITED INDEX Page Condensed Consolidated Balance Sheets 2 - 3 Condensed Consolidated Statements of Operations 4 Condensed Consolidated St |
|
September 21, 2018 |
Exhibit 99.2 CYREN LTD. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS For the Six Months Ended June 30, 2018 The following discussion and analysis should be read in conjunction with our interim condensed consolidated financial statements as of and for the six months ended June 30, 2018, appearing elsewhere in this Form 6-K, our audited consolidated financial |
|
September 21, 2018 |
CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Of |
|
September 6, 2018 |
CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Of |
|
September 6, 2018 |
Exhibit 1 PRESS RELEASE Cyren Launches GoCloud Partner Program New global channel program enables partners to drive growth and revenue with industry-leading cloud security products McLean, VA – September 6, 2018 – Cyren (NASDAQ: CYRN), a leader in cloud security, today announced the launch of its GoCloud Partner Program, a new global channel program that provides resellers, managed service providers, and distributors with the opportunity to predictably grow recurring revenue streams through 100% cloud security products. |
|
August 29, 2018 |
CYRN / CYREN Ltd. REPORT OF FOREIGN PRIVATE ISSUER (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2018 Commission File Number 000-26495 Cyren Ltd. (Translation of Registrant’s name into English) 10 Ha-Menofim St, 5th Floor, Herzliya 4672561, Israel (Address of Principal Executive Offic |